Class Denied In Paxil Case

Law360, New York (January 26, 2007, 12:00 AM EST) -- Plaintiffs alleging that GlaxoSmithKline PLC knew about risks related to adolescents’ use of antidepressant Paxil, but failed to warn doctors and the public, were denied class certification Thursday.

The ruling in the U.S. District Court in the Eastern District of Pennsylvania denied the certification of a national class. The plaintiffs sought to represent “all persons whose children under the age eighteen committed or attempted to commit suicide while using the drug,” the decision said.

In denying class certification, Judge Timothy J. Savage said that class action...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.